425: Strive & Semler Merger: Cautionary Statement Filed

Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statement risks.

Summary

• A communication was reposted on X.com by Jeff Walton, Chief Risk Officer of Strive, Inc., on December 31, 2025, concerning Strive's proposed business combination with Semler Scientific, Inc.
• The filing serves as a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus for important information about the proposed transaction.
• Details regarding participants in the solicitation of proxies, including directors and executive officers, are referenced in other SEC filings.
• This communication does not constitute an offer to sell or solicit securities or votes.

Sentiment

Score: 4

Explanation: The filing is primarily a cautionary statement regarding a proposed merger, heavily emphasizing risks and uncertainties associated with forward-looking statements. While it concerns a significant corporate event, the tone is cautious and highlights potential negative outcomes rather than positive developments.

Positives

• NA

Negatives

• NA

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The filing outlines the outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including anticipated strategic and financial benefits, the expected impact on future financial performance, the timing of closing, and the ability to successfully integrate the combined businesses. However, these forward-looking statements are presented with significant caveats, emphasizing that actual results could differ materially due to numerous inherent risks and uncertainties.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., reposted the communication on X.com.
• Management of Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

NA

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Dilution for Strive's Class A common stock shareholders due to the issuance of additional shares.

Next Steps

• Stockholders of Semler Scientific are required to approve the proposed transaction.
• Strive and Semler Scientific may file additional relevant documents with the SEC concerning the proposed transaction.
• Successful integration of the combined businesses is a future objective.

Key Dates

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, risk management, corporate governance, Bitcoin treasury